Clinical Trial Update: LITT Combined With Early Use of Temozolomide for Recurrent Glioblastomas [Phase 1, Phase 2]

View source ↗

Summary

A clinical trial update evaluating Laser Interstitial Thermal Therapy (LITT) combined with early temozolomide in recurrent glioblastoma across Phase 1 and Phase…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Glioblastoma

Drugs mentioned

• LITT (laser interstitial thermal therapy)
• Temozolomide (Temozolomide)

Snippet

Sponsor: Beijing Tiantan Hospital | Conditions: Recurrent Glioblastoma | Phase 1, Phase 2 | Status: UNKNOWN